Lv4
680 积分 2023-10-13 加入
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies
1个月前
已完结
In vivo reprogramming of cytotoxic effector CD8 + T cells via fractalkine-conjugated mRNA-LNP
1个月前
已完结
Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells
2个月前
已完结
Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells
2个月前
已完结
Impact of soluble BCMA and non–T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma
3个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
10个月前
已完结
Outcomes of PLAT-02 and PLAT-03: Evaluating CD19 CAR T-Cell Therapy and CD19-expressing T-APC Support in Pediatric B-ALL
1年前
已关闭
皖公网安备34019202002308
